Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy With UVADEX for the Treatment of Patients With Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD)

NCT01380535 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT01380535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01380535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy With UVADEX for the Treatment of Patients With Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD)
Lead sponsor
Mallinckrodt
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2011
Completion date
March 31, 2015
Enrollment
60 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

chronic graft versus host disease